Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Share-based Compensation (2019 - 2025)

SRx Health Solutions (SRXH) has disclosed Share-based Compensation for 11 consecutive years, with $2.9 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Share-based Compensation rose 2800.0% year-over-year to $2.9 million, compared with a TTM value of $3.7 million through Jun 2025, up 3604.0%, and an annual FY2023 reading of $1.8 million, down 40.9% over the prior year.
  • Share-based Compensation was $2.9 million for Q2 2025 at SRx Health Solutions, up from $280000.0 in the prior quarter.
  • Across five years, Share-based Compensation topped out at $4.1 million in Q4 2021 and bottomed at -$2.8 million in Q3 2021.
  • Average Share-based Compensation over 5 years is $648388.9, with a median of $290000.0 recorded in 2023.
  • The sharpest move saw Share-based Compensation crashed 98.35% in 2021, then surged 2800.0% in 2025.
  • Year by year, Share-based Compensation stood at $4.1 million in 2021, then plummeted by 97.56% to $100000.0 in 2022, then soared by 73.0% to $173000.0 in 2023, then skyrocketed by 145.09% to $424000.0 in 2024, then skyrocketed by 583.96% to $2.9 million in 2025.
  • Business Quant data shows Share-based Compensation for SRXH at $2.9 million in Q2 2025, $280000.0 in Q1 2025, and $424000.0 in Q4 2024.